Trial intelligence / Profile preview

Bisoprolol and perindopril for cardiotoxicity prevention in breast cancer

NCT04588935Phase 2Completed

Start
Jul 2019
Primary completion
Feb 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of bisoprolol, perindopril in Cardiotoxicity. Started Jul 2019; status: completed.

02

Drugs

bisoprololperindopril
03

Conditions

Cardiotoxicity

Beyond the preview

Go deeper on NCT04588935.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04588935.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call